D
DNA Script
Biotech & Life Sciences · Le Kremlin-Bicêtre, France · Founded 2014
Transforming how molecular biology translates to human health, personalized medicine, and synthetic biology MoreLess
DNA Script revolutionizes DNA synthesis with its proprietary enzymatic technology. The company has developed SYNTAX™️, the world's first benchtop DNA printer, which integrates innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. DNA Script serves clients in genomics research and personalized medicine, providing a cutting-edge tool that simplifies and accelerates DNA synthesis. Operating in the biotechnology market, the company generates revenue through the sale of its SYNTAX™️ system and related consumables. By enabling rapid and efficient DNA synthesis, DNA Script aims to drive advancements in genomics and personalized healthcare.
Keywords: DNA synthesis, enzymatic technology, benchtop printer, genomics research, personalized medicine, enzyme engineering, nucleotide chemistries, biotechnology, SYNTAX system, healthcare.
Company overview
DNA Script company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- Le Kremlin-Bicêtre, France
- Employees
- 132
- Open positions
- 5
- Dealroom signal
- 66.3
Valuation & funding
DNA Script funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jan 2022 | $35M | $825M | Irving Investors · Baillie Gifford · T. Rowe Price · EureKARE | ↗ |
| SERIES COther financing | Oct 2021 | $165M | $660M | Farallon Capital Management · EQT Life Sciences · Danaher · Alexandria Venture Investments | — |
| SERIES BOther financing | Jul 2020 | $50M | $200M | Bpifrance · M Ventures · Agilent · Casdin Capital | — |
| SERIES BOther financing | May 2019 | $39M | $154M | Sofinnova Partners · Illumina Ventures · Kurma Partners · Eurazeo | — |
| GRANTOther financing | Jul 2018 | $2.7M | — | Bpifrance | ↗ |
| GRANTOther financing | Apr 2018 | Bpifrance · European Innovation Council | ↗ | ||
| SERIES AOther financing | Sep 2017 | Sofinnova Partners · Eurazeo · M Ventures · Illumina Ventures | ↗ | ||
| SUPPORT PROGRAMOther financing | Jan 2017 | Paris Biotech Santé | ↗ | ||
| SEEDOther financing | Jun 2016 | Sofinnova Partners · Eurazeo · Kurma Partners | — | ||
| SUPPORT PROGRAMOther financing | Jun 2015 | Agoranov | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $10M | 0% | −$30M | -290.3% |
| 2025 | $10M | 0% | −$30M | -290.3% |
| 2024 | $10M | 0% | −$30M | -290.3% |
| 2023 | $10M | +21.6% | −$30M | -290.3% |
| 2022 | $8.4M | +59% | −$30M | -352.9% |
| 2021 | $5.3M | +183.3% | −$30M | -561.1% |
| 2020 | $1.9M | — | −$13M | -701.9% |
Growth signals
DNA Script website traffic
Latest recorded traffic for DNA Script is 6.5K monthly website visits, up 25% over the last three months. DNA Script's team declined 8.3% over the past year.
Hiring
Open positions at DNA Script
Current openings linked to this company in Dealroom.
Comparisons
DNA Script compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
DNA Script's talent
Source: Dealroom Talent Intelligence.
Investors
30 investors on DNA Script's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where DNA Script has talent and traffic
team presence
In the news
Latest news about DNA Script
Recent press, funding announcements, and product moves mentioning DNA Script — open to read from the original sources.
Market sentiment
What the market is saying about DNA Script
An AI-synthesized read of the highest-engagement posts about DNA Script on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See DNA Script’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.